Insights

Innovative CNS Solutions Neuroderm specializes in developing next-generation drug-device combination therapies for central nervous system disorders, presenting opportunities to collaborate on advanced treatments for conditions like Parkinson's disease.

Recent Clinical Success Positive phase 3 trial results for ND0612 demonstrate the company's strong clinical pipeline, indicating potential for strategic partnerships, licensing, or purchase of innovative CNS therapies.

Acquisition and Growth Having been acquired by Mitsubishi Tanabe Pharma for over a billion dollars, Neuroderm is positioned as a high-value target for partners interested in expanding CNS product portfolios and entering the neurotech market.

Funding and Revenue With recent funding of $75 million and revenues between $50 million and $100 million, Neuroderm offers attractive investment and partnership opportunities in the healthcare innovation sector.

European Regulatory Progress Receiving scientific advice from the EMA highlights Neuroderm’s commitment to regulatory approval, facilitating opportunities for international market expansion and collaborative development programs.

Neuroderm Tech Stack

Neuroderm uses 8 technology products and services including Umbraco, Cloudflare, Twemoji, and more. Explore Neuroderm's tech stack below.

  • Umbraco
    Content Management System
  • Cloudflare
    Content Management System
  • Twemoji
    Font Scripts
  • ScrollReveal
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • PHP
    Programming Languages
  • reCAPTCHA
    Security
  • Google Tag Manager
    Tag Management

Media & News

Neuroderm's Email Address Formats

Neuroderm uses at least 1 format(s):
Neuroderm Email FormatsExamplePercentage
First@neuroderm.comJohn@neuroderm.com
85%
Last@neuroderm.comDoe@neuroderm.com
8%
FirstL@neuroderm.comJohnD@neuroderm.com
4%
FLast@neuroderm.comJDoe@neuroderm.com
3%

Frequently Asked Questions

Where is Neuroderm's headquarters located?

Minus sign iconPlus sign icon
Neuroderm's main headquarters is located at 3 Pekeris Street Rehovot, 7670212 IL. The company has employees across 4 continents, including AsiaEuropeNorth America.

What is Neuroderm's phone number?

Minus sign iconPlus sign icon
You can contact Neuroderm's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neuroderm's official website and social media links?

Minus sign iconPlus sign icon
Neuroderm's official website is neuroderm.com and has social profiles on LinkedIn.

What is Neuroderm's NAICS code?

Minus sign iconPlus sign icon
Neuroderm's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Neuroderm have currently?

Minus sign iconPlus sign icon
As of October 2025, Neuroderm has approximately 171 employees across 4 continents, including AsiaEuropeNorth America. Key team members include Chief Executive Officer: K. I.Chief Technology Officer: U. D.Vp Human Resources: A. N.. Explore Neuroderm's employee directory with LeadIQ.

What industry does Neuroderm belong to?

Minus sign iconPlus sign icon
Neuroderm operates in the Pharmaceutical Manufacturing industry.

What technology does Neuroderm use?

Minus sign iconPlus sign icon
Neuroderm's tech stack includes UmbracoCloudflareTwemojiScrollRevealLodashPHPreCAPTCHAGoogle Tag Manager.

What is Neuroderm's email format?

Minus sign iconPlus sign icon
Neuroderm's email format typically follows the pattern of First@neuroderm.com. Find more Neuroderm email formats with LeadIQ.

How much funding has Neuroderm raised to date?

Minus sign iconPlus sign icon
As of October 2025, Neuroderm has raised $75M in funding. The last funding round occurred on Dec 07, 2016 for $75M.

When was Neuroderm founded?

Minus sign iconPlus sign icon
Neuroderm was founded in 2003.

Neuroderm

Pharmaceutical ManufacturingRehovot, Israel51-200 Employees

NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.

By developing next-generation drug-device combination solutions for central nervous system disorders, we aspire to make a meaningful difference in patients’ lives and drive future healthcare connectivity.

Our mission is to address the challenges of the future healthcare and wellbeing ecosystem. We are passionately driven to reduce disease burden and improve the quality of life of patients and their families through innovative drug-device combination therapies and technologies.

Section iconCompany Overview

Headquarters
3 Pekeris Street Rehovot, 7670212 IL
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
51-200

Section iconFunding & Financials

  • $75M

    Neuroderm has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Dec 07, 2016 in the amount of $75M.

  • $50M$100M

    Neuroderm's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $75M

    Neuroderm has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Dec 07, 2016 in the amount of $75M.

  • $50M$100M

    Neuroderm's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.